Abstract:DNA damage can lead to mutations that can alter the function of oncogenes or tumor suppressor genes, thus promoting the development of cancer. p53 plays a multifaceted and complex role in the DNA damage response and cancer progression and is known as the 'guardian of the gene'. When DNA damage occurs, p53 is activated through a series of post-translational modifications, which stabilize the protein and enhance its function as a transcription factor. It regulates processes including cell cycle checkpoints, DNA repair and apoptosis, thereby preventing the spread of damaged DNA and maintaining genome integrity. On the one hand, p53 can initiate cell cycle arrest and induce cells to enter the G1/S and G2/M checkpoints, preventing cells with damaged DNA from continuing to proliferate and gaining time for DNA repair. At the same time, p53 can promote the activation of DNA repair pathways, including base excision repair, nucleotide excision repair and other repair pathways, to ensure the integrity of genetic material. If the damage is too severe to repair, p53 will trigger the apoptosis process to eliminate potential cancer risks in time. p53 also plays a pivotal role in cancer progression. Mutations in the p53 gene are frequently found in many cancers, and the mutated p53 not only loses its normal tumor suppressor function but may even acquire pro-cancer activity. Therefore, we also discuss therapeutic strategies targeting the p53 pathway, such as the use of small-molecule drugs to restore the function of wild-type p53, the inhibition of negative regulatory factors and synthetic lethality approaches for p53-deficient tumors. This review therefore highlights the important role of p53 in maintaining genomic stability and its potential in therapeutic strategies for cancer.

[Advances on Mutant P53 Research].

Mutant P53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Mutant p53 in Cancer Progression and Targeted Therapies

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Functional Diversity of P53 in Human and Wild Animals

Gain-of-function mutant p53 in cancer progression and therapy

Mutant p53 in cancer therapy-the barrier or the path.

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

Small Molecule Agents Targeting the P53-Mdm2 Pathway for Cancer Therapy

Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway

Mutant p53 as a guardian of the cancer cell

Progress and Prospects: Roles of P53 in Tumor Development

The Development of P53-Targeted Therapies for Human Cancers

Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

Network effect of Wt-mutant p53 interactions and implications on p53 gene therapy.

p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

P53 Gain-of-function Cancer Mutants Induce Genetic Instability by Inactivating ATM